Pritchard was one of several doctors who led advocacy training sessions at IDWeek, a conference about infectious diseases ...

Oct. 29—While many recognize Día de Muertos (Day of the Dead) for its colorful ofrendas (altars), vibrant cempasúchil (Mexican marigolds) flowers and elegantly dressed Catrina and Catrín skeletons, ...

A network analysis of 581 HIV patients in Kampala identified separate acute and chronic brain health phenotypes, with depression, bipolar and psychosis spectra clustering together and opportunistic ...

Funding up-and-coming HIV researchers, the amfAR Mathilde Krim Fellowship in Biomedical Research has produced a strong track ...

MPhil and PhD students benefiting from scholarships under the Post-COVID-19 Skills Development and Productivity Enhancement ...

A structured review found that CRISPR diagnostics for maternal–infant HIV, hepatitis B and syphilis care remain clinically unready, with HIV early infant diagnosis offering the strongest near-term d ...

Favorable safety profile exhibited across three Phase 1 studies and Phase 2 cryptococcal meningitis study - Turletricin demonstrated clinically ...

The presentations cover two FDA-approved antibiotics marketed by Innoviva Specialty Therapeutics, ceftobiprole (ZEVTERA ®) and zoliflodacin (NUZOLVENCE ® ), and represent the company’s ongoing ...

Gilead Sciences, Inc. (Nasdaq: GILD) will present new findings from its HIV and antiviral research and development programs ...

Gilead Sciences, Inc. will present new findings from its HIV and antiviral research and development programs at IDWeek 2026, taking place October 21-24 in Washington, D.C. The 28 presentations, ...

At San Francisco General’s famed Ward 86 clinic, researchers gave 10 people with HIV an intensive series of experimental immune treatments. Seven controlled the virus for a time after stopping daily ...